India’s Serum Institute dispatches first COVAX vaccines for WHO's global supply

Published: Updated:

India’s Serum Institute, the world’s largest vaccine manufacturer, dispatched on Tuesday its first batch of vaccine shots for the COVAX global inoculation program.

The global vaccine procurement and equitable distribution effort aims to secure vaccines for at least the most vulnerable 20 percent in every country.

COVAX, led by the World Health Organization and the GAVI alliance, has struck agreements with manufacturers for two billion doses in 2021 and has the option for another billion.

For more coronavirus news, visit our dedicated page.

This includes 1.1 billion doses from the Serum Institute, which is producing the AstraZeneca and Novavax vaccines.

WHO Southeast Asia tweeted photos of the first shipments being loaded onto a truck at Serum’s manufacturing facility in Pune in western India.

For all the latest headlines, follow our Google News channel online or via the app.

Serum has already supplied the Indian government with millions of doses of the AstraZeneca vaccine as well as other poorer nations.

The company’s head Adar Poonawalla on Sunday urged other countries to be “patient,” saying it had been instructed to prioritize its home market over exports.

Read more:

Lives on the line if world fails with COVID-19 vaccine logistics, warns COVAX chief

Vaccine giant says its been instructed to prioritize India

UK auditing Indian COVID-19 vaccine site amid scramble for shots: Sources